Login
Home
Charts
Search
Watchlist
Products

Sun Pharmaceutical Industries Ltd

SUNPHARMA·NSE
₹1,846.40-1.20%Tue, 22 Sept '26 15:58
Industry:Pharma - Formulators
Indices:

Sun Pharmaceutical Industries Ltd

SUNPHARMA
NSE
₹1,846.40
-1.20%
|Tue, 22 Sept '26 15:58
SOICxStockScans Reports
Industry
Pharma - Formulators
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹4,43,013Cr
Close
Close Price
₹1,846.40
Industry
Industry
Pharma - Formulators
PE
Price To Earnings
36.63
PS
Price To Sales
7.39
Revenue
Revenue
₹59,911Cr
Rev Gr TTM
Revenue Growth TTM
11.41%
PAT Gr TTM
PAT Growth TTM
16.92%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
12,19212,38111,98312,65313,29113,67512,95913,85114,47815,52114,61215,300
Growth YoY
Revenue Growth YoY%
11.310.19.66.09.010.58.19.58.913.512.810.5
Expenses
ExpensesCr
9,0138,9048,9489,0459,3529,6669,2439,5509,95110,57210,65810,882
Operating Profit
Operating ProfitCr
3,1793,4773,0353,6083,9394,0093,7164,3024,5274,9483,9544,418
OPM
OPM%
26.128.125.328.529.629.328.731.131.331.927.128.9
Other Income
Other IncomeCr
294180504533354149251-35447089459520
Interest Expense
Interest ExpenseCr
49357462695249751007886100
Depreciation
DepreciationCr
633622650655626631664701730732775739
PBT
PBTCr
2,7913,0002,8163,4243,5983,4763,2543,1734,1684,2273,5514,099
Tax
TaxCr
3904321495525675591,0948701,0318268281,188
PAT
PATCr
2,4012,5682,6672,8713,0312,9182,1612,3033,1373,4012,7242,911
Growth YoY
PAT Growth YoY%
6.217.432.242.626.213.6-19.0-19.83.516.626.126.4
NPM
NPM%
19.720.722.322.722.821.316.716.621.721.918.619.0
EPS
EPS₹
9.910.511.111.812.712.19.09.513.014.011.312.1
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
12,19212,38111,98312,65313,29113,67512,95913,85114,47815,52114,61215,300
Growth YoY
Revenue Growth YoY%
11.310.19.66.09.010.58.19.58.913.512.810.5
Expenses
ExpensesCr
9,0138,9048,9489,0459,3529,6669,2439,5509,95110,57210,65810,882
Operating Profit
Operating ProfitCr
3,1793,4773,0353,6083,9394,0093,7164,3024,5274,9483,9544,418
OPM
OPM%
26.128.125.328.529.629.328.731.131.331.927.128.9
Other Income
Other IncomeCr
294180504533354149251-35447089459520
Interest Expense
Interest ExpenseCr
49357462695249751007886100
Depreciation
DepreciationCr
633622650655626631664701730732775739
PBT
PBTCr
2,7913,0002,8163,4243,5983,4763,2543,1734,1684,2273,5514,099
Tax
TaxCr
3904321495525675591,0948701,0318268281,188
PAT
PATCr
2,4012,5682,6672,8713,0312,9182,1612,3033,1373,4012,7242,911
Growth YoY
PAT Growth YoY%
6.217.432.242.626.213.6-19.0-19.83.516.626.126.4
NPM
NPM%
19.720.722.322.722.821.316.716.621.721.918.619.0
EPS
EPS₹
9.910.511.111.812.712.19.09.513.014.011.312.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
28,48731,57826,48929,06632,83833,49838,65443,88648,49752,57858,46259,911
Growth
Revenue Growth%
3.810.8-16.19.713.02.015.413.510.58.411.211.4
Expenses
ExpensesCr
20,32921,48920,88122,75825,86325,03028,41132,23935,51037,49241,97142,063
Operating Profit
Operating ProfitCr
8,15810,0895,6086,3086,9748,46810,24411,64712,98715,08616,49117,847
OPM
OPM%
28.631.921.221.721.225.326.526.526.828.728.229.8
Other Income
Other IncomeCr
-27623-112-189391-3,447-3,4914638961,4731,9041,537
Interest Expense
Interest ExpenseCr
523400518555303141127172238231339364
Depreciation
DepreciationCr
1,0381,2651,5001,7532,0532,0802,1442,5292,5572,5752,9382,976
PBT
PBTCr
6,5719,0483,4793,8105,0102,7994,4819,40811,08813,75215,11916,045
Tax
TaxCr
9141,2129116018235151,0768481,4392,7723,5543,872
PAT
PATCr
5,6577,8362,5683,2094,1872,2853,4068,5619,64810,98011,56512,173
Growth
PAT Growth%
3.138.5-67.225.030.5-45.449.1151.412.713.85.316.9
NPM
NPM%
19.924.89.711.012.86.88.819.519.920.919.820.3
EPS
EPS₹
18.929.08.711.115.712.113.635.339.945.647.850.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
28,48731,57826,48929,06632,83833,49838,65443,88648,49752,57858,46259,911
Growth
Revenue Growth%
3.810.8-16.19.713.02.015.413.510.58.411.211.4
Expenses
ExpensesCr
20,32921,48920,88122,75825,86325,03028,41132,23935,51037,49241,97142,063
Operating Profit
Operating ProfitCr
8,15810,0895,6086,3086,9748,46810,24411,64712,98715,08616,49117,847
OPM
OPM%
28.631.921.221.721.225.326.526.526.828.728.229.8
Other Income
Other IncomeCr
-27623-112-189391-3,447-3,4914638961,4731,9041,537
Interest Expense
Interest ExpenseCr
523400518555303141127172238231339364
Depreciation
DepreciationCr
1,0381,2651,5001,7532,0532,0802,1442,5292,5572,5752,9382,976
PBT
PBTCr
6,5719,0483,4793,8105,0102,7994,4819,40811,08813,75215,11916,045
Tax
TaxCr
9141,2129116018235151,0768481,4392,7723,5543,872
PAT
PATCr
5,6577,8362,5683,2094,1872,2853,4068,5619,64810,98011,56512,173
Growth
PAT Growth%
3.138.5-67.225.030.5-45.449.1151.412.713.85.316.9
NPM
NPM%
19.924.89.711.012.86.88.819.519.920.919.820.3
EPS
EPS₹
18.929.08.711.115.712.113.635.339.945.647.850.4

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
241240240240240240240240240240240
Reserves
ReservesCr
32,74136,40038,07441,16945,02546,22347,77155,75563,42771,97883,330
Current Liabilities
Current LiabilitiesCr
13,14417,88719,86417,34015,70616,14617,20819,90616,98418,19422,622
Non Current Liabilities
Non Current LiabilitiesCr
5,3193,0932,4542,6323,4212,0411,5331,5221,3901,4202,283
Total Liabilities
Total LiabilitiesCr
55,53061,41064,51664,69468,25267,66769,80880,74485,50092,1011,08,785
Current Assets
Current AssetsCr
29,94132,95431,63631,06931,65430,44234,86539,86243,43352,59463,860
Non Current Assets
Non Current AssetsCr
25,58928,45732,88033,62536,59837,22534,94340,88242,06739,50744,925
Total Assets
Total AssetsCr
55,53061,41064,51664,69468,25267,66769,80880,74485,50092,1011,08,785
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
241240240240240240240240240240240
Reserves
ReservesCr
32,74136,40038,07441,16945,02546,22347,77155,75563,42771,97883,330
Current Liabilities
Current LiabilitiesCr
13,14417,88719,86417,34015,70616,14617,20819,90616,98418,19422,622
Non Current Liabilities
Non Current LiabilitiesCr
5,3193,0932,4542,6323,4212,0411,5331,5221,3901,4202,283
Total Liabilities
Total LiabilitiesCr
55,53061,41064,51664,69468,25267,66769,80880,74485,50092,1011,08,785
Current Assets
Current AssetsCr
29,94132,95431,63631,06931,65430,44234,86539,86243,43352,59463,860
Non Current Assets
Non Current AssetsCr
25,58928,45732,88033,62536,59837,22534,94340,88242,06739,50744,925
Total Assets
Total AssetsCr
55,53061,41064,51664,69468,25267,66769,80880,74485,50092,1011,08,785

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
6,6867,0823,9072,1966,5556,1708,9854,95912,13514,07212,419
Investing Cash Flow
Investing Cash FlowCr
-4,372-4,222-3,371-681-2,589536-5,725-7,944-690-5,306-11,344
Financing Cash Flow
Financing Cash FlowCr
-1,889-2,285-1,539-2,731-5,715-5,980-5,1932,376-6,710-7,906-2,513
Net Cash Flow
Net Cash FlowCr
426575-1,003-1,215-1,749726-1,934-6084,735860-1,437
Free Cash Flow
Free Cash FlowCr
3,3533,4922,013-9665,1055,0977,5502,8959,96412,0058,906
CFO To PAT
CFO To PAT%
118.290.4152.268.4156.6270.1263.857.9125.8128.2107.4
CFO To EBITDA
CFO To EBITDA%
82.070.269.734.894.072.987.742.693.493.375.3
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
6,6867,0823,9072,1966,5556,1708,9854,95912,13514,07212,419
Investing Cash Flow
Investing Cash FlowCr
-4,372-4,222-3,371-681-2,589536-5,725-7,944-690-5,306-11,344
Financing Cash Flow
Financing Cash FlowCr
-1,889-2,285-1,539-2,731-5,715-5,980-5,1932,376-6,710-7,906-2,513
Net Cash Flow
Net Cash FlowCr
426575-1,003-1,215-1,749726-1,934-6084,735860-1,437
Free Cash Flow
Free Cash FlowCr
3,3533,4922,013-9665,1055,0977,5502,8959,96412,0058,906
CFO To PAT
CFO To PAT%
118.290.4152.268.4156.6270.1263.857.9125.8128.2107.4
CFO To EBITDA
CFO To EBITDA%
82.070.269.734.894.072.987.742.693.493.375.3

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,97,2191,64,9991,18,8621,14,98884,5051,43,3842,19,4912,35,8793,88,8124,16,3934,21,6474,43,013
Price To Earnings
Price To Earnings
43.423.756.843.122.449.467.127.840.638.136.736.6
Price To Sales
Price To Sales
6.95.24.54.02.64.35.75.48.07.97.27.4
Price To Book
Price To Book
6.04.53.12.81.93.14.64.26.15.85.05.3
EV To EBITDA
EV To EBITDA
23.615.721.218.612.316.621.120.429.427.025.124.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
69.566.363.064.364.867.066.569.471.973.874.574.5
OPM
OPM%
28.631.921.221.721.225.326.526.526.828.728.229.8
NPM
NPM%
19.924.89.711.012.86.88.819.519.920.919.820.3
ROCE
ROCE%
17.221.18.38.510.15.89.315.216.918.817.517.5
ROE
ROE%
17.121.46.77.89.34.97.115.315.215.213.813.8
ROA
ROA%
10.212.84.05.06.13.44.910.611.311.910.610.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,97,2191,64,9991,18,8621,14,98884,5051,43,3842,19,4912,35,8793,88,8124,16,3934,21,6474,43,013
Price To Earnings
Price To Earnings
43.423.756.843.122.449.467.127.840.638.136.736.6
Price To Sales
Price To Sales
6.95.24.54.02.64.35.75.48.07.97.27.4
Price To Book
Price To Book
6.04.53.12.81.93.14.64.26.15.85.05.3
EV To EBITDA
EV To EBITDA
23.615.721.218.612.316.621.120.429.427.025.124.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
69.566.363.064.364.867.066.569.471.973.874.574.5
OPM
OPM%
28.631.921.221.721.225.326.526.526.828.728.229.8
NPM
NPM%
19.924.89.711.012.86.88.819.519.920.919.820.3
ROCE
ROCE%
17.221.18.38.510.15.89.315.216.918.817.517.5
ROE
ROE%
17.121.46.77.89.34.97.115.315.215.213.813.8
ROA
ROA%
10.212.84.05.06.13.44.910.611.311.910.610.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Sun Pharmaceutical Industries Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/9qae8g9diew7mjxyqvv9nxhx.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/xkrvljths28opphhx6vqvajx.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/swbsa5o22lm2gp1j60a8j8da.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/zlur82rshejey8nxictqmx2r.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/0m8sjoe2abeibah1oakaglrz.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/yg6q4hdv56hchyrisn0e6z37.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/ow3d5nzk7an92xegc7y2ox2w.pdf
  • Q1 FY2025 Earnings Call Transcript (Jun 2024, PDF): https://www.stockscans.in/document/efh25uc5pheinostvxwchusk.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/egcdfkhvxay854zoz3t2sd1j.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/ocpnmw1wulu95n7d0yryc73e.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/nqbjhsbmgyujeob13zu67asn.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/p5e52xfwy23iezbdicn40zfq.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/egia7oaltiei1va2l6zdb2ej.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/nvpm6uw8td92gdu8h36qfwm5.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/80aihji3xeghz88jej0zi6ij.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/1enzswu6cf87q2f4ebxw9who.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/dtde2juv7ab3qmg4g2re2cve.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/wkkd3rmt3zi8dhcgph8fxyoa.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/83fmde9gkfvqw6g2x4yqwlfg.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/pear70o2bburptmr4dt72ly8.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/8jks5hneqc33tnjism6lmdrx.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/r3ylisbn8b4g6oyw7zs0eop0.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/hy5odsev3fw3em7y69s1r8rw.pdf
  • Q1 FY2025 Investor Presentation (Jun 2024, PDF): https://www.stockscans.in/document/ybbxkrs85a6ctc757m6jyqa8.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/1cnxw5pj0cp5l4bxtxjr3usj.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/zblbkya677qyozkfqpgdlx0b.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/l0a44g7eefieozrewenawl3s.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/koptmffmyyj1n51a159ntlza.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/wtvcfkfbssshbom97fu88q3b.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/ruhuld3sjlzbfm7ymrrj4sry.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/gg45jfi8vyg9bkzowp47lmcu.pdf

Concall Transcript Summaries — Sun Pharmaceutical Industries Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3ASUNPHARMA/transcript-notes/202606/9qae8g9diew7mjxyqvv9nxhx.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3ASUNPHARMA/transcript-notes/202603/xkrvljths28opphhx6vqvajx.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3ASUNPHARMA/transcript-notes/202512/swbsa5o22lm2gp1j60a8j8da.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3ASUNPHARMA/transcript-notes/202509/zlur82rshejey8nxictqmx2r.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3ASUNPHARMA/transcript-notes/202503/0m8sjoe2abeibah1oakaglrz.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3ASUNPHARMA/transcript-notes/202412/yg6q4hdv56hchyrisn0e6z37.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3ASUNPHARMA/transcript-notes/202409/ow3d5nzk7an92xegc7y2ox2w.pdf
  • Q1 FY2025 Concall Transcript Summary (Jun 2024): https://www.stockscans.in/company/NSE%3ASUNPHARMA/transcript-notes/202406/efh25uc5pheinostvxwchusk.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies